Avastin in Combination With Chemotherapy for RAS Mutant Unresectable Colorectal Liver-limited Metastases

PHASE4CompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

December 31, 2017

Study Completion Date

June 30, 2019

Conditions
Colorectal Neoplasms
Interventions
DRUG

avastin

Drug: avastin On day 1 of a 14 day treatment cycle, patients received a 2-hour infusion of avastin (5mg/kg) followed by chemotherapy of mFOLFOX6 until progressive disease or unacceptable toxicity.

DRUG

mFOLFOX6

mFOLFOX-6 (oxaliplatin, 85mg/m2 on day 1 infused during 2 hours;LV400mg/m2 on days 1 infused during 2 hours, followed by FU 400 mg/m2 intravenous bolus then 2400 mg/m2 continuous infusion for 46 hours)

Trial Locations (1)

200000

Zhongshan Hospital, Fudan University, Shanghai

All Listed Sponsors
lead

Xu jianmin

OTHER

NCT01972490 - Avastin in Combination With Chemotherapy for RAS Mutant Unresectable Colorectal Liver-limited Metastases | Biotech Hunter | Biotech Hunter